Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
Stefan Radtke1, Dnyanada Pande1, Mark Enstrom1
1Stem Cell and Gene Therapy Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Blood Advances
|December 19, 2022
Summary
No abstract available in PubMed .
More Related Videos
10:13An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
Published on: January 12, 2018
9.0K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.8K
